Answer
Aug 08, 2025 - 10:08 AM
CagriSema is composed of cagrilintide, an amylin analogue, and semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. This combination targets pathways involved in appetite regulation and energy balance, enhancing weight loss and glycemic control, valuable for individuals managing obesity or type 2 diabetes.
